27th Annual EuroMeeting

Back to Agendas

CLEARING THE PATH FOR INNOVATIONS IN DRUG DEVELOPMENT

Session Chair(s)

John A. Lisman, LLM, MPharm

Advocaat/Attorney, Consultant, Trainer

Lisman Legal Life Sciences B.V., Netherlands

This session will focus on the activities stakeholders perform to prepare and implement the novelties in the Clinical Trial Regulation. What will Member States do to lift their new responsibilities? How will industry adapt to the new regulatory set-up and where do patients’ foresee strengths and challenges?

Speaker(s)

Pathways for Early Access to Medicines - How can the use of existing tools be improved from an industry perspective?

Sabine Atzor, MPharm, RPh

F. Hoffmann-La Roche Ltd, Switzerland

Head of EU Regulatory Policies

Member States’ Activities for Implementing Innovative Initiatives in Respect of Clinical Trials

Christian Schneider, DrMed

PharmaLex, Denmark

Head of Biopharma Excellence and Chief Medical Officer (Biopharma)

Patients’ Concerns in Respect of the Development of New Medicines

Bettina Ryll

MPNE, Vision Zero Cancer, Sweden

Member of the First EU Cancer Mission Board

Have an account?